Clinical Trial Update: Miltefosine for Brazilian Visceral Leishmaniasis [Phase 1, Phase 2]

View source ↗

Summary

Miltefosine was studied in Phase 1 and Phase 2 trials for visceral leishmaniasis in Brazil (Kala Azar), but the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Impavido (miltefosine)

Snippet

Sponsor: AB Foundation | Conditions: Kala Azar | Phase 1, Phase 2 | Status: TERMINATED